Skip to main content

Table 3 Effect of IPTsc on anaemia during the intervention period

From: Efficacy and safety of intermittent preventive treatment for malaria in schoolchildren: a systematic review

  Study site Drug regime No of children Prevalence of anaemia (%) PE (95 % CI)
Clarke [24] Bondo SP + AQ (four-monthly) 2604 6.3 50 (41–53)
   Placebo 2302 12.6
Barger [25] Kollé SP + AS 96 17.7 40 (9–61)
   AQ + AS 100 16 46 (17–65)
   Control 98 29.6
Nankabirwa [27] Tororo DP (monthly) 717a 12 40 (29–49)
   DP (three and five monthly) 716a 17 14 (2–23)
   Placebo 736a 20
  1. PE protective effect, No number, SP + AQ sulfadoxine-pyrimethamine plus amodiaquine, SP + AS sulfadoxine-pyrimethamine plus artesunate, AQ + AS amodiaquine plus artesunate, DP dihydroartemisinin-piperaquine, % percentage
  2. aTotal tests